To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
104 Current news of High-Tech Gründerfonds Managementrss
|You can refine your search further. Select from the filter options on the left to narrow down your results.|
Funding to Advance Pipeline of Anti-fibrotic Molecules into the Clinic
Alentis Therapeutics, the Swiss biotech developing breakthrough treatments for fibrotic diseases, announced that it has raisedUSD67 (CHF60) millionin a Series B financing round. The funding will be used primarily for proof-of-concept clinical trials of Alentis’ first in class, Claudin-1 ...
Seed financing round for female-founded circular bioeconomy startup traceless materials
The funding lays the foundation to bring an advanced natural material to market that solves the global plastic pollution. The Hamburg-based, female-founded startup traceless materials has developed a holistically sustainable alternative for plastics and bioplastics that is fully compostable in ...
Biotech startup to advance personalized medicine for cancer patients
PreComb Therapeutics announced the successful completion of the seed financing round led by Kinled Austria, the High-Tech Gründerfonds and FiveT capital, in addition to participations from other investors.Patrick Aisher, managing partner at Kinled Austria, joined the company’s board of ...
Twenty-One Semiconductors successfully closes seed financing round with High-Tech Gründerfonds
High-Tech Gründerfonds (HTGF) invests in the start-up Twenty-One Semiconductors (21S) as part of a first round of financing. The spin-off from the University of Stuttgart produces semiconductor-based laser crystals for biomedical applications. These crystals enable the realization of laser ...
Newly founded biotech company ActiTrexx receives funding of € 3.5 million
ActiTrexx GmbH, a new biotech spin-off from the University Medical Center Mainz, Germany, has successfully closed its Series A financing. A consortium led by LBBW Venture Capital GmbH with participation from MediVentures GmbH, High-Tech Gründerfonds (HTGF) and Investitions- und Strukturbank ...
GeneQuine Biotherapeutics Secures more than €9 Million
GeneQuine Biotherapeutics GmbH, a biotech company focused on the development of gene therapy for musculoskeletal disorders, announced that it has raised €5.4 million in Series A financing and €3.65 million non-dilutive funding bringing the total amount raised to €9.05 million. The Series A ...
i3 Membrane receives 7 figure sum for development and market launch
Four investors are financing the further growth of i3 Membrane GmbH. High-tech venture capital investor HTGF from Bonn, Germany, and three private investors are together investing a 7 figure sum in the further development and market launch of new separation technology for biological molecules. ...
LignoPure secures € 2.2 Million seed round
LignoPure invented a unique approach to replace plastics through utilization of wood waste and the team just closed its seed round with HTGF, IFH and Tanovis AG to scale its own technology for the transformation of lignin – a byproduct of the pulp and paper industries and biorefineries – into ...
Start-up announces $24 million Series A financing and appoints Jason T. Gammack as CEO
Resolve Biosciences, the pioneer in Molecular Cartography™, announced the completion of a $24 million Series A financing round and the appointment of Co-founder Jason T. Gammack as Chief Executive Officer. The company’s Molecular Cartography platform is a groundbreaking multi-analyte and highly ...
International pool invests ~ 2 Mio € in medicine start-up mediaire
HTGF, primeCROWD and LIFTT are part of an international round for the development of “Deep learning diagnostic” which allows faster, more accurate and safer MRI analysis. Expansion into European markets will start in 2021 accompanied by a significant expansion of product portfolio mediaire, the ...